New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
Trial ID or NCT#
Status
Purpose
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effect on the body of combining cyclophosphamide with cisplatin, etoposide, and bleomycin in treating children who have newly diagnosed malignant germ cell tumors that are not in the brain and gonads.
Official Title
Pilot Study of Cisplatin, Etoposide, Bleomycin and Escalating Dose Cyclophosphamide Therapy for Children With High Risk Malignant Germ Cell Tumors
Eligibility Criteria
Investigator(s)
Contact us to find out if this trial is right for you.
CONTACT
Min Wang
(650) 736-4281
View on ClinicalTrials.gov
About this Clinical Trial
Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
Your Message Will Go To
Min Wang6507364281